Wall Street brokerages expect INC Research Holdings, Inc. (NASDAQ:INCR) to announce earnings per share of $0.59 for the current quarter, Zacks Investment Research reports. Six analysts have made estimates for INC Research’s earnings, with the highest EPS estimate coming in at $0.74 and the lowest estimate coming in at $0.55. INC Research posted earnings of $0.67 per share during the same quarter last year, which suggests a negative year-over-year growth rate of 11.9%. The firm is scheduled to issue its next earnings report on Tuesday, February 27th.

On average, analysts expect that INC Research will report full-year earnings of $2.39 per share for the current fiscal year, with EPS estimates ranging from $2.14 to $2.60. For the next financial year, analysts anticipate that the business will post earnings of $2.56 per share, with EPS estimates ranging from $2.37 to $3.10. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side research firms that follow INC Research.

INC Research (NASDAQ:INCR) last announced its quarterly earnings data on Thursday, November 9th. The company reported $0.54 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.63 by ($0.09). The firm had revenue of $592.21 million during the quarter, compared to analysts’ expectations of $604.95 million. INC Research had a positive return on equity of 14.42% and a negative net margin of 4.29%. The business’s revenue for the quarter was up 128.2% on a year-over-year basis. During the same period last year, the company earned $0.64 earnings per share.

A number of analysts have recently issued reports on INCR shares. TheStreet raised shares of INC Research from a “c” rating to a “b-” rating in a research note on Monday, November 6th. Robert W. Baird set a $46.00 target price on shares of INC Research and gave the company a “buy” rating in a research note on Thursday, November 16th. Jefferies Group reaffirmed a “buy” rating and set a $55.00 target price on shares of INC Research in a research note on Friday, November 10th. Zacks Investment Research raised shares of INC Research from a “hold” rating to a “buy” rating and set a $58.00 target price for the company in a research note on Wednesday, September 27th. Finally, SunTrust Banks cut their target price on shares of INC Research to $50.00 and set a “buy” rating for the company in a research note on Friday, December 1st. One analyst has rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $50.56.

A number of institutional investors and hedge funds have recently bought and sold shares of INCR. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in INC Research by 14.8% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,765 shares of the company’s stock valued at $103,000 after acquiring an additional 228 shares in the last quarter. Pacad Investment Ltd. purchased a new position in shares of INC Research in the 2nd quarter worth $123,000. Riverhead Capital Management LLC purchased a new position in shares of INC Research in the 2nd quarter worth $128,000. Victory Capital Management Inc. grew its stake in shares of INC Research by 17.6% in the 2nd quarter. Victory Capital Management Inc. now owns 2,377 shares of the company’s stock worth $139,000 after buying an additional 356 shares in the last quarter. Finally, Personal Capital Advisors Corp purchased a new position in shares of INC Research in the 3rd quarter worth $234,000. 99.50% of the stock is owned by institutional investors.

Shares of INC Research (NASDAQ:INCR) traded up $0.75 during midday trading on Friday, hitting $42.85. 1,276,538 shares of the stock were exchanged, compared to its average volume of 966,945. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.99. The stock has a market capitalization of $4,283.36, a PE ratio of 18.83, a PEG ratio of 1.29 and a beta of 1.08. INC Research has a 1 year low of $33.60 and a 1 year high of $61.10.

COPYRIGHT VIOLATION WARNING: This piece was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright & trademark laws. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/12/21/inc-research-holdings-inc-incr-expected-to-announce-earnings-of-0-59-per-share.html.

INC Research Company Profile

INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.

Get a free copy of the Zacks research report on INC Research (INCR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for INC Research (NASDAQ:INCR)

Receive News & Ratings for INC Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research and related companies with MarketBeat.com's FREE daily email newsletter.